Who
Jean Pierre Garnier
Director
Company insider
Files Form 4 as: Director, BioAge Labs; Director, Carrier Global; Director, Radius Health; Director, Rtx.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $3.0M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 13 Mar 2006
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 15 Apr 2026filed 17 Apr 2026 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $195K3,330.487 at $58.55 | filing |
| 15 Apr 2026filed 17 Apr 2026 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $195K3,330.49 at $58.55 | filing |
| 5 Jun 2025filed 9 Jun 2025 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 Apr 2025filed 11 Apr 2025 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $195K3,208.82 at $60.77 | filing |
| 25 Sep 2024filed 27 Sep 2024 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 19 Aug 2024filed 27 Sep 2024 | BIOA BioAge Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —141,609 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $186K3,484.45 at $53.38 | filing |
| 20 Apr 2023filed 21 Apr 2023 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $310K6,831.2 at $45.38 | filing |
| 15 Aug 2022filed 15 Aug 2022 | Radius Healthoption or derivative | SEC FORM 4 Code D | $36K10,000 at $3.60 | filing |
| 15 Aug 2022filed 15 Aug 2022 | Radius Health | SEC FORM 4 Code U | $268K26,800 at $10.00 | filing |
| 15 Aug 2022filed 15 Aug 2022 | Radius Health | SEC FORM 4 Code D | $55K5,500 at $10.00 | filing |
| 14 Apr 2022filed 18 Apr 2022 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $330K7,994.19 at $41.28 | filing |
| 14 Jan 2022filed 25 Jan 2022 | Radius Healthoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Jan 2022filed 25 Jan 2022 | Radius Health | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 19 Apr 2021filed 20 Apr 2021 | CARR Carrier Globaloption or derivative · Machinery | SEC FORM 4 Code A | $365K8,320.04 at $43.87 | filing |
| 22 Feb 2021filed 23 Feb 2021 | Radius Health | SEC FORM 4 Code A | —5,500 | filing |
| 22 Feb 2021filed 23 Feb 2021 | Radius Healthoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 21 Jan 2021filed 25 Jan 2021 | Radius Healthoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
RTX (NYSE: RTX) Secures $8.7 Billion In Defense Contracts, Strengthening Long-Term Revenue OutlookRTX · foreignpolicyjournal.com · 18 Oct 2026RTX Corporation (NYSE: RTX) Poised For Q3 Earnings Beat With Strong Aerospace And Defense DemandRTX · foreignpolicyjournal.com · 16 Oct 2026Large Caps Push Toward Record Highs As Small Caps Stumble: (TSX: ATD), (NYSE: RTX), (NYSE: LMT), (NYSE: SAP), (TSX: SLF) In FocusRTX · foreignpolicyjournal.com · 14 Oct 2026
0 headlines in the last 90 days name Jean Pierre Garnier; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.